Researchers in Korea are growing a brand new strategy to localized brachytherapy that would enhance the therapy of keloid scars. The technique makes use of injectable, biodegradable hyaluronic acid microgels that act as tiny radiation reservoirs inside goal tissue. By combining speedy radiolabeling with localized supply, the platform goals to beat limitations of typical radiation therapy whereas providing higher flexibility and precision. The research highlights a promising step towards focused, minimally invasive microbrachytherapy.
Keloids are irregular, fibroproliferative scars that type when overactive fibroblasts produce extreme collagen after pores and skin damage. In contrast to bizarre scars, they will prolong past the unique wound and trigger itching, ache, and tenderness. Present therapies, together with surgical procedure, corticosteroid injections, lasers, and radiotherapy, might require extended therapy and may be related to recurrence. Though radiotherapy can suppress keloid progress, typical external-beam approaches wrestle to exactly goal small, irregular lesions whereas sparing surrounding wholesome tissue.
To deal with this problem, researchers from Pusan Nationwide College, led by Prof. Seung Yun Yang, who additionally serves as CEO of SNVIA Co., Ltd., developed an injectable system designed to ship radiation immediately inside keloid tissue.
Prof. Yang explains, “We developed an “off-the-shelf” microbrachytherapy strategy utilizing injectable, biodegradable hyaluronic acid (HA) microgels for keloid therapy.“
The researchers investigated whether or not freeze-dried HA microgels may present speedy and sustained native supply of radioactive iodine-131 (¹³¹I) whereas minimizing systemic publicity. This paper was made out there on-line on August 10, 2026 and will probably be printed in Quantity 398 of the Journal of Managed Launch on October 10, 2026.
The researchers fabricated uniform, biodegradable HA microgels utilizing microfluidic know-how and freeze-drying, making a porous construction that would quickly soak up radioactive answer. The microgels have been then labeled with ¹³¹I and evaluated utilizing patient-derived keloid fibroblasts to evaluate cytotoxicity and apoptosis. Their therapeutic efficacy, radioactive retention, biodistribution, and security have been subsequently evaluated in mice carrying patient-derived keloid tissue.
The microgels enabled speedy and environment friendly radiolabeling. “By way of absorption-mediated speedy radiolabeling, our freeze-dried microgels obtain excessive labeling effectivity (>90%) of iodine-131 in lower than 10 minutes,” shares Prof. Yang. Following injection, the microgels remained localized inside keloid tissue for as much as 14 days. In vitro, ¹³¹I-HA microgels at doses ≥10 MBq induced greater than 80% keloid fibroblast dying inside 48 hours, primarily by apoptosis. Intralesional injection additionally lowered keloid dimension by about 70% after 2 weeks in a xenograft mannequin, with out off-target biodistribution or harm to surrounding wholesome tissues. No vital abnormalities have been noticed in thyroid operate, blood parameters, or main organs.
The group believes the platform may simplify the preparation and supply of localized brachytherapy. On-site radiolabeling might scale back radioactive waste and logistical calls for whereas permitting therapy to be tailor-made to particular person lesions. The strategy may doubtlessly be tailored for different localized tumors, though additional research are wanted to evaluate its broader purposes.
Lastly, Prof. Yang concludes, “This know-how gives a minimally invasive strategy to ship exact native radiotherapy, overcoming the focusing on limitations of typical exterior beam radiation for small, irregular lesions.”
Total, the findings present a promising preclinical basis for focused microbrachytherapy for keloids. Longer-term research are nonetheless wanted to judge recurrence, immune responses, dose distribution, and scientific security.
Supply:
Journal reference:
Kim, S., et al. (2026). Off-the-shelf microbrachytherapy utilizing on-site quick radiolabeling for keloid therapy. Journal of Managed Launch. DOI: 10.1016/j.jconrel.2026.115239. https://www.sciencedirect.com/science/article/abs/pii/S0168365926006437?via%3Dihub